Professor Martin Tobin holds a UK Medical Research Council Senior Clinical Fellowship and is Professor of Genetic Epidemiology and Public Health at the University of Leicester, UK.
He has established, led and co led national and international genomic epidemiology studies including the collaborative studies of genomics of lung function and COPD for the SpiroMeta and UK BiLEVE which have identified key genomic loci now known to influence lung function and COPD risk. The Busselton Health Study has contributed data in collaboration with Professor Tobin in these studies.
The work of his group crosses disease areas and extends to a range of traits and to multimorbidity.
He is principal investigator for GeCIP and for the EXCEED study, which aims to improve drug target validation.
A light lunch follows the presentation.
A light lunch follows the presentation.